Dr Catherine Thomas, OD | |
420 N 2nd St, Amite, LA 70422-2420 | |
(985) 748-8750 | |
Not Available |
Full Name | Dr Catherine Thomas |
---|---|
Gender | Female |
Speciality | Optometry |
Experience | 3 Years |
Location | 420 N 2nd St, Amite, Louisiana |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003589466 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
152W00000X | Optometrist | 1943-879AT (Louisiana) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Precision Optical Of Hammond, Inc. | 5294861019 | 3 |
Tiger Vision, L.l.c. | 0840292850 | 8 |
News Archive
A new study has revealed a significant link between cardiovascular disease and stroke risk in women who began menstruating before the age of 12.
The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.
Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.
Existing evidence suggests pornography may negatively affect some individuals, but it does not qualify as a public health crisis, and calling it one could cause harm.
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 7 days ago
Provider Name | Tiger Vision, L.l.c. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1063471985 PECOS PAC ID: 0840292850 Enrollment ID: O20070205000186 |
News Archive
A new study has revealed a significant link between cardiovascular disease and stroke risk in women who began menstruating before the age of 12.
The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.
Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.
Existing evidence suggests pornography may negatively affect some individuals, but it does not qualify as a public health crisis, and calling it one could cause harm.
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 7 days ago
Provider Name | Precision Optical Of Hammond, Inc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1093851339 PECOS PAC ID: 5294861019 Enrollment ID: O20100331000961 |
News Archive
A new study has revealed a significant link between cardiovascular disease and stroke risk in women who began menstruating before the age of 12.
The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.
Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.
Existing evidence suggests pornography may negatively affect some individuals, but it does not qualify as a public health crisis, and calling it one could cause harm.
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Catherine Thomas, OD 420 N 2nd St, Amite, LA 70422-2420 Ph: (985) 748-8750 | Dr Catherine Thomas, OD 420 N 2nd St, Amite, LA 70422-2420 Ph: (985) 748-8750 |
News Archive
A new study has revealed a significant link between cardiovascular disease and stroke risk in women who began menstruating before the age of 12.
The board of directors of Walgreen Co. today declared a regular quarterly dividend of 22.5 cents per share, a 28.6 percent increase over the year ago dividend. The dividend is payable June 12, 2012, to shareholders of record May 21, 2012.
Akonni Biosystems, a molecular diagnostic (MDx) company focused on providing rapid and highly scalable solutions for research and infectious disease testing, today announced the worldwide launch of their TruTip product line for extracting DNA and RNA from samples with volumes ranging from 100 µl to 1000 µl or more.
Existing evidence suggests pornography may negatively affect some individuals, but it does not qualify as a public health crisis, and calling it one could cause harm.
The U.S. Food and Drug Administration today approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
› Verified 7 days ago
Thomas Eye Care And Associates Optometrist Medicare: Medicare Enrolled Practice Location: 420 N 2nd St, Amite, LA 70422 Phone: 985-748-8750 | |
Lillian Marie Forstall, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 60007 W Way Dr, Amite, LA 70422 Phone: 985-748-8096 Fax: 985-748-4376 | |
Julia Reimold, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 60007 W Way Dr, Amite, LA 70422 Phone: 985-748-8096 Fax: 985-748-4376 | |
Coralis Dara Millien, OD Optometrist Medicare: Medicare Enrolled Practice Location: 60007 W Way Dr, Amite, LA 70422 Phone: 985-748-8096 Fax: 985-748-4376 | |
Dr. Christopher Thomas, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 420 N 2nd St, Amite, LA 70422 Phone: 985-981-1216 | |
Dr. Richard Hunter Bond, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 60007 West Way Drive, Amite, LA 70422 Phone: 985-748-8096 Fax: 985-748-4376 |